BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 14701788)

  • 1. Problems with nomenclature and pharmacodynamics in trophoblastic disease.
    Kohorn EI
    J Clin Oncol; 2004 Jan; 22(1):203-4; author reply 204. PubMed ID: 14701788
    [No Abstract]   [Full Text] [Related]  

  • 2. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [When does chemotherapy of trophoblastic disease should be stopped?].
    Kobayashi O; Matsui H; Takamizawa H
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2405-10. PubMed ID: 3033103
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of methotrexate in the chemotherapy of gestational trophoblastic neoplasms.
    Sobrero A; Bertino JR
    Adv Exp Med Biol; 1984; 176():343-54. PubMed ID: 6093467
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
    Kohorn EI
    J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
    Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
    Ayhan A; Yapar EG; Deren O; Kişnişçi H
    J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate monotherapy for high-risk gestational trophoblastic neoplasia after therapy with etoposide, methotrexate, and dactinomycin: a case report.
    Taran A; Ignatov A; Smith B; Bischoff J; Costa SD
    Am J Obstet Gynecol; 2008 Nov; 199(5):e6-8. PubMed ID: 18984073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for trophoblastic neoplasms in the Philippines.
    Gonzales RB
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):669-74. PubMed ID: 3012792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Course of pregnancy and labor following cytostatic treatment of trophoblastic tumors].
    Richter P; Buchholz K; Lotze W
    Zentralbl Gynakol; 1987; 109(9):586-9. PubMed ID: 3039759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for trophoblastic disease: current standards.
    Kendall A; Gillmore R; Newlands E
    Curr Opin Obstet Gynecol; 2002 Feb; 14(1):33-8. PubMed ID: 11801874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
    Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
    J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of chemotherapeutic refractory cases based on human chorionic gonadotropin values among patients with low-risk persistent trophoblastic disease treated with 8-day methotrexate-folinic acid.
    Shigematsu T; Hirakawa T; Yahata H; Sonoda T; Kinukawa N; Nakano H
    Eur J Gynaecol Oncol; 2003; 24(2):113-6. PubMed ID: 12701958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
    Khoo SK; Jones IS
    Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of low-risk metastatic gestational trophoblastic disease.
    Jones WB
    J Reprod Med; 1987 Sep; 32(9):653-6. PubMed ID: 2822918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
    Wang S; An R; Han X; Zhu K; Xue Y
    Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for trophoblastic disease: current standards.
    Kendall A; Gillmore R; Newlands E
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):48-54. PubMed ID: 12597349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.